PUBLIC - Croatia, the War, and the Future

INFANRIX-IPV+Hib,
Combined Diphtheria,
Tetanus, acellular
Pertussis,inactivated Polio
and Haemophilus
influenzae type B
conjugate Vaccine
Influvac (inactivated
influenza vaccine, surface
antigen)
Infusol (solution for
infusion)
powder and suspension
for preparation of
suspension for injection
suspension for injection
solution for intravenous
infusion
Inspra 25 mg tablets film coated tablets
Inspra 50 mg tablets film coated tablets
Instillagel 11 mL gel
Instillagel 6 mL gel
Insulatard HM 100
Insulatard Penfill
Integrilin solution for
infusion 0.75 mg/mL
Integrilin solution for
injection 2 mg/mL
solution for injection (for
s.c. use)
suspension for
subcutaneous injection
solution for infusion
solution for injection
Intralipid 10% emulsion for infusion
Intralipid 10% emulsion for infusion
GlaxoSmithKline
Biologicals s.a., Rue
de lInstitut 89,
Rixensart, Belgium
Solvay
Pharmaceuticals B.V.,
Veerweg 12, 8121 AA
Olst, the Netherlands
Pliva Croatia Ltd., Ulica
grada Vukovara 49,
Zagreb, Republic of
Croatia
Pharmacia Limited,
Whalton Road,
Morpeth,
Northumberland
NE613YA, Great
Britain
Pharmacia Limited,
Whalton Road,
Morpeth,
Northumberland
NE613YA, Great
Britain
Almed GmbH,
Motzener Str. 41,
Berlin, Germany
Almed GmbH,
Motzener Str. 41,
Berlin, Germany
Novo Nordisk A/S,
Novo Allé, DK-2880
Bagsvaerd, Denmark
Novo Nordisk A/S,
Novo Alle, Bagsvaerd,
Denmark Novo Nordisk
Production SAS, 45,
Avenue d' Orleans,
Chartres, France
Schering-Plough Labo
N.V., Heist-op-den-
Berg, Belgium and
Glaxo Operations UK
Ltd., Great Britain
Schering-Plough Labo
N.V., Heist-op-den-
Berg, Belgium and
Glaxo Operations UK
Ltd., Great Britain
Fresenius Kabi Austria
GmbH, Graz, Austria
and Fresenius Kabi
AB, Uppsala, Sweden
Fresenius Kabi AB,
Uppsala, Sweden
in a box
Box with 1 glass syringe
containing 0.5 mL of
suspension (component
Infanrix IPV), 1 glass bottle
with powder (component Hib)
and 2 needles with protection
Box with 1 pre-filled syringe
(glass, type I) with 1 dose of
vaccine (0.5 mL of
suspension)
10 glass vials with 500 mL of
solution, supplied in a box
30 (3x10) film coated tablets
in a nontransparent PVC/Al
blister, supplied in a carton
box
30 (3x10) film coated tablets
in a nontransparent PVC/Al
blister, supplied in a carton
box
10 syringes each containing
11 mL of gel in a blister,
supplied in a box
10 syringes each containing
6 mL of gel in a blister,
supplied in a box
10 mL of suspension in a
glass bottle, supplied in a
box
5 glass cartridges with 3 mL
of suspension in a blister,
supplied in a box
One glass vial with 10 mL of
solution, supplied in a box
One glass vial with 10 mL of
solution, supplied in a box
Glass infusion bottle
containing 500 mL of
emulsion, 10 bottles in a
carton box
Plastic bag ("Excel")
containing 500 mL of
emulsion for infusion with two
attachments for drug
administration and for
infusion, one small bag
containing oxygen absorber,
and one bag with solution for
packaging airtightness
14509/11 WS/jj 301
ANNEX II DGF 2A / DG K 2 EN
YES
YES
YES YES
YES YES YES YES
YES YES YES YES
YES YES
YES YES
YES YES
YES YES
YES YES YES YES
YES YES YES YES
YES YES
YES YES